Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBAVIRIN vs RIFAPENTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBAVIRIN vs RIFAPENTINE: Safety Overview

Metric RIBAVIRIN RIFAPENTINE
Total FAERS Reports 43,397 298
Deaths Reported 2,494 8
Death Rate 5.7% 2.7%
Hospitalizations 8,495 88
Average Patient Age 55.7 yrs 46.5 yrs
% Female Patients 44.3% 55.6%
FDA Approval Date Apr 18, 2008 Jun 22, 1998
Manufacturer Aurobindo Pharma Limited sanofi-aventis U.S. LLC
Route ORAL ORAL
Marketing Status Discontinued Prescription